Operational and strategic update

Similar documents
Nufarm Interim Results

2016 Full Year Results

First half underlying EBIT in line with guidance; business on track to deliver full year earnings growth Highlights

Capital raising. May Doug Rathbone Managing Director and Chief Executive Officer. Kevin Martin Chief Financial Officer

For personal use only

For personal use only

For personal use only

RWC reports strong first half results with continued business growth. EBITDA guidance for FY2018 increased.

For personal use only

Managing Director s Address Annual General Meeting of Shareholders - Melbourne Thursday, December 7, 2017 at am. G A Hunt

9 May Half Year Results

Results presentation Half-year August 2017

Results presentation Full-year 2017

Appendix 4D PARAGON CARE LIMITED. Reporting Period: Financial Half Year ended 31 Dec 2014

FY2014 Full year results

Half Year results and outlook

Paul Maguire Philip Bennett Paul Witheridge Managing Director Chief Financial Officer Chief Financial Officer

Qube delivers revenue and earnings growth while completing strategic acquisitions for the future

2018 Full Year Results 20 November 2018

1H18 Results Presentation Sid Takla Interim Chief Executive Officer Lyndal York Chief Financial Officer

For personal use only

2017 Full Year Results. Tuesday 21 November 2017

Analyst Pack 1H December Challenger Limited providing our customers with financial security for retirement. CHALLENGER.COM.

Half Year Results Presentation

Photo by James Ball - Coffey International Limited FY2013 Half Year Results Presentation. 11 February 2013

Half year result. 26 August 2016

TUI GROUP. Full year results to 30 September 2018

For personal use only. Appen Limited. Global Leader in Language Technology Solutions. FY2014 Results Presentation

NEWS RELEASE FOR IMMEDIATE RELEASE

Summary Report. Good progress on sales, profits and new international distribution. OVERVIEW HIGHLIGHTS FOR THE PERIOD ENDED 31 DECEMBER

GRAINCORP LIMITED: GNC INVESTOR PRESENTATION FINANCIAL YEAR ENDED 30 SEPTEMBER 2017

HY 2018 Results Presentation August 28, 2018

For personal use only

Half Year Report 2018

Full Year results and outlook

TAG PACIFIC HALF YEAR RESULT

For personal use only

For personal use only

1H FY19 RESULTS PRESENTATION 25 February 2019

Business Update. Q3 and 9M 2018

FULL YEAR RESULT DEMONSTRATES STRONG BUSINESS MOMENTUM

For personal use only

AMP driving value and growth. Andrew Mohl Chief Executive Officer

Interim Results 2019 March 2019

INVESTOR PRESENTATION HY18 AND OUTLOOK FY18

AGM Presentation November 2016

COCHLEAR FINANCIAL RESULTS FOR YEAR ENDED JUNE 2017

Interim Results for the 6 months to 30 September NOVEMBER 2010

Full Year Results 2014

2017 Half-Year Results

Profit/(Loss) before income tax 112, ,323. Income tax benefit/(expense) 11 (31,173) (37,501)

Select Harvests Limited ( SHV )

2011 Interim Result. 18 August CEO Brett Chenoweth CFO Peter Myers

Board of Directors Zurich, 24 March, 2009 Dufry Presentation - Full Year 2009 Results

AUB GROUP LTD FULL YEAR RESULTS

Q Results presentation

Sigma Pharmaceuticals Limited

Talanx Strategy Frankfurt, 23 October Torsten Leue, CEO

For personal use only

SAI GLOBAL LIMITED. Financial Report Half-Year Ended 31 December 2012

Qube delivers another solid financial performance Further progress on Moorebank Project with strong tenant interest

Investor Presentation

Select Harvests Limited ( SHV )

ANNUAL RESULTS 30 JUNE 2015

Continued focus on core disciplines delivers sound 2017 interim result

For personal use only GTN Limited Results for the 12 months ending 30 June 2016

H1 08 H1 08 pro forma

Interim Report Q1 FY 18

Annual EVM Results 2015 Investor and analyst presentation Zurich, 16 March We make the world more resilient.

Results Presentation. 18 August gwagroup.com.au

Forward-looking statements

Fluidra 1H RESULTS. 30 July de abril de 2017

For personal use only

TOURISM HOLDINGS LTD FY16 INTERIM RESULTS PRESENTATION. 23 February 2016

INTERIM RESULTS PRESENTATION SIX MONTHS TO 30 JUNE 2018

February 25, Q Earnings Presentation

For personal use only. Investor Presentation November 2012

FY13 INTERIM RESULTS 13 December 2012

AUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITED HALF YEAR FY14 RESULTS PRESENTATION WEDNESDAY 30 APRIL 2014

24 August 2018 FY18. Results. Presentation

Vita Group (VTG)! Results Presentation!

UBS Emerging Companies Conference - 17 October 2007

Preliminary results for the year ended 31 March 2014

Forward-looking statements

William Blair & Company 30 th Annual Growth Stock Conference

Q PRESENTATION. Rolf Barmen (CEO) Birte Strander (CFO) Oslo, 8 th May

Q1/16 Conference Call May 10th, 2016

Thomas Cook Group. Interim Results 6 months ended 31 March May 2010

Full-year Financial Report for the year ended 31 December 2016

For personal use only. JB Hi-Fi Limited. HY18 Results Presentation

ANALYSTS CONFERENCE 2011

Second Quarter 2011 Earnings Conference Call. 18 May 2011

Q Business Update. May 22, 2016

TUI GROUP. Full year results to 30 September 2017

SCALES CORPORATION LIMITED GROWING YOUR DIVERSIFIED AGRIBUSINESS. Half Year Results For the six months ended 30 June August 2018

A Firm Grip. Investor and Analyst Presentation. on the Occasion of the Release of the 3-Monthly Results 2009

HALF YEAR RESULTS. For the half year ended 31 December 2016

For personal use only

Important Notice. The sum totals throughout this presentation may not add exactly due to rounding differences.

26 FEBRUARY 2019 FULL YEAR RESULTS FOR THE YEAR ENDED 31 DECEMBER 2018 SIGNIFICANT PROGRESS ON STRATEGIC PRIORITIES AND IMPROVED PROFIT MARGIN

Transcription:

Operational and strategic update Doug Rathbone Managing Director/CEO Paul Binfield Chief Financial Officer Robert Reis Group Executive, Corporate Strategy & External Affairs April 17, 2013

2013 Interim results (6 months to January 31, 2013) Underlying EBIT* up by 25% to $47.3m Improvement in GP margin and EBIT margin Improved business performance in key overseas regions Australian result reflects challenging first half conditions Underlying NPAT impacted by foreign exchange losses * EBIT before material items 2

2013 Interim results (6 months to January 31, 2013) Result underlines strength of Nufarm s global platform and expanding product base Importance of a diversified business Reflects improving performance of key growth regions, including North & South America and Europe Shows continued growth in seeds technologies platform...and is a reminder that Australia remains a key earnings contributor to the group 3

Changes in Australia BASF distribution arrangements cease March 2014 Nufarm will have 'replacement' portfolio Leadership position in horticulture will be leveraged Potential to generate stronger integrated gross margin on business we retain Roundup trademark agreement terminates in August 2013 Nufarm retains proprietary chemistry and products and is repositioning glyphosate portfolio to Nufarm brands We will continue to assess implications of changes in our business and in the market generally. Strong commitment to maintenance of leadership position in Australian market. 4

Outlook for balance of year Australia will not make up lost ground in first half and poor start to second half. Full year outcome dependant on seasonal conditions over coming months but margin pressure remains North America looking positive and business expected to maintain improvement on FY'12 over the full year Brazil will deliver strong growth over full year, however second half contribution may be lower year on year due to different outlook for commodity prices and smaller saffrinha crop Europe positioned to generate improved full year outcome. Seeds segment positioned to generate higher full year earnings Underlying EBIT and NPAT now forecast to be below that of previous year Underlying EBIT range: $180m - $200m Underlying NPAT range: $80m - $95m 5

Impact of foreign exchange Underlying NPAT decline largely attributable to impact of FX rates on financing activities Movement in FX rates had little net impact on Underlying EBIT Majority of FX loss during the half related to financing activities and occurred prior to the new capital structure being implemented and largely remains unrealised (Net FX loss in 1H 13 of $9.2m compares to gain of $14.4m in 1H 12) New capital structure has reduced our net underlying financing FX exposures Underlying EBIT at constant FX (A$ millions) Six months ended 31 January 2013 Actual 2012 Constant FX (1) 2012 Actual Revenue 934.4 833.9 862.7 Underlying EBIT 47.3 38.0 37.8 Underlying NPAT 10.6 25.0 23.9 Impact of FX on net financing costs (A$ millions) Six months ended 31 January 2013 2012 Net FX gains / (losses) on Nufarm Step-Up Securities (2) n/a 8.0 Net Underlying FX gains / (losses) Net FX gains / (losses) incl. in net financing costs (9.2) 14.4 (9.2) 22.4 Strong A$ relative to BRL impacted translation of sales revenue Movement in foreign currency exchange rates had little net impact on overall profitability in the period Note: Underlying EBIT and NPAT exclude material items. (1) 2012 Actuals converted at 2013 foreign currency exchange rates. (2) Net FX gains/(losses) on NSS treated as a material item in the prior period. Net underlying FX gains/(losses) reported within net financing costs (format consistent with July 2012 disclosures) FX profile has changed in the last 18 months as the new capital structure has been implemented Majority of net underlying FX gains/(losses) occurred prior to execution of the High Yield Bond in Oct 2012 6

Working capital & operating cash flow Focus on working capital management continues to deliver improvements Net working capital position at 31 January 2013 reflects strong growth in Brazil and inventory build-up in Australia due to seasonal build-up ahead of winter crop and impact of the unfavourable weather conditions Partially offset by improved working capital management Seasonal nature of the business results in net working capital at January being greater than at July Typical cycle sees working capital build in the first half peaking March/April, before falling to low in July/August Operating cash flow also includes class action settlement ($46.7m, non recurring item) Average net working capital trend Net working capital Six months ended 31 January 1200.0 1150.0 1100.0 53.9% 50.2% 48.7% 45.3% 43.4% 2013 2012 Change Receivables 808.8 790.4 2.3% p Inventories 812.6 649.8 25.0% p Payables 588.7 475.1 23.9% p 1050.0 Net working capital (NWC) 1,032.7 965.1 7.0% p 1000.0 Operating cash flow (148.2) (71.1) q 950.0 Average NWC (1) 976.1 996.6 q 900.0 Avg NWC/Sales (%) (2) 43.4% 48.7% q 850.0 FY10 FY11 HY12 FY12 HY13 Average Net Working Capital (ANWC) ($m) ANWC / Sales (%) (1) Average NWC (ANWC) is the average NWC balance calculated over 12 months (2) ANWC/Sales is ANWC divided by the last 12 months sales revenue 7

Capital structure Capital structure strengthened and debt maturities extended, providing platform for growth US$325 million high yield bond successfully executed in Oct 2012 Provides diversification of funding sources and 7-year tenor at a competitive interest rate (coupon of 6.375% p.a.) Takes advantage of the natural hedge available through our US$ earnings Syndicated facility matures in Nov 2014. Recently increased size by $25 million to A$406 million following admission of an additional financial institution, HSBC, into the facility Trade receivables facility provides A$250m available funding and is renewed annually Longer term regional facilities recently put in place further diversify and provide local currency funding Facility commitments January 2012 (A$ millions) 700.0 Facility commitments January 2013 (A$ millions) 700.0 600.0 600.0 500.0 500.0 400.0 400.0 300.0 300.0 200.0 200.0 100.0 100.0 0.0 <1yr 1-2 yrs 2-3 yrs 3-4 yrs 4-5 yrs 5-6 yrs 6-7 yrs 0.0 <1yr 1-2 yrs 2-3 yrs 3-4 yrs 4-5 yrs 5-6 yrs 6-7 yrs 8

Strategic update: 2011: Comprehensive strategic review of the business Utilised '3 Horizons' framework Horizon 1: Short term Resetting the base Horizon 2: Medium term Building a disciplined and entrepreneurial company Horizon 3: Long term Securing a sustainably profitable industry position Clear strategic growth plan 9

Corporate growth strategy Protect / enhance value of our core positions Invest in new growth opportunities Generate improved returns Growing into higher value and more defendable product and market segments 10

Key strategic initiatives Differentiate Reinforce/ enhance brand values Expand/diversify product portfolio Support growth of seeds platform Define, communicate and adhere to return targets and KPIs Build the strength and capabilities of the organisation Ensure cost competitiveness and improved efficiencies 11

Corporate strategy framework Specific regional and business strategies 12

Summary: Good progress and significant change in the business Commitment to increased discipline Stronger focus on innovation across all areas of the business Appropriate changes to and strengthening of the organisation We are strongly focused on executing our strategic growth plan Current seasonal pressures in Australia underline the importance/value of a diversified geographic platform and a continued move into higher value product and market segments Shorter term objectives closely tied to long term vision 13